> top > docs > PubMed:23672597 > annotations

PubMed:23672597 JSONTXT

Annnotations TAB JSON ListView MergeView

Allie

Id Subject Object Predicate Lexical cue
SS1_23672597_7_0 833-854 expanded denotes fasting blood glucose
SS2_23672597_7_0 856-859 abbr denotes FBG
SS1_23672597_8_0 1024-1042 expanded denotes C-reactive protein
SS2_23672597_8_0 1044-1047 abbr denotes CRP
SS1_23672597_8_1 1050-1065 expanded denotes body mass index
SS2_23672597_8_1 1067-1070 abbr denotes BMI
SS1_23672597_8_2 1086-1100 expanded denotes blood pressure
SS2_23672597_8_2 1102-1104 abbr denotes BP
SS1_23672597_8_3 1107-1137 expanded denotes health related quality of life
SS2_23672597_8_3 1139-1144 abbr denotes HRQoL
SS1_23672597_9_0 1158-1180 expanded denotes Analysis of covariance
SS2_23672597_9_0 1182-1188 abbr denotes ANCOVA
SS1_23672597_14_0 1925-1949 expanded denotes high-density lipoprotein
SS2_23672597_14_0 1951-1954 abbr denotes HDL
AE1_23672597_7_0 SS1_23672597_7_0 SS2_23672597_7_0 abbreviatedTo fasting blood glucose,FBG
AE1_23672597_8_0 SS1_23672597_8_0 SS2_23672597_8_0 abbreviatedTo C-reactive protein,CRP
AE1_23672597_8_1 SS1_23672597_8_1 SS2_23672597_8_1 abbreviatedTo body mass index,BMI
AE1_23672597_8_2 SS1_23672597_8_2 SS2_23672597_8_2 abbreviatedTo blood pressure,BP
AE1_23672597_8_3 SS1_23672597_8_3 SS2_23672597_8_3 abbreviatedTo health related quality of life,HRQoL
AE1_23672597_9_0 SS1_23672597_9_0 SS2_23672597_9_0 abbreviatedTo Analysis of covariance,ANCOVA
AE1_23672597_14_0 SS1_23672597_14_0 SS2_23672597_14_0 abbreviatedTo high-density lipoprotein,HDL

PubmedHPO

Id Subject Object Predicate Lexical cue
T1 297-302 HP_0000618 denotes blind
T2 456-474 HP_0000855 denotes insulin resistance

chenxin_473849_800_3

Id Subject Object Predicate Lexical cue
T1 563-574 DP denotes prediabetes
T10 1334-1351 CI denotes Jiangtang Xiaozhi
T11 1874-1891 CI denotes Jiangtang Xiaozhi
T12 2259-2276 CI denotes Jiangtang Xiaozhi
T13 671-678 CI denotes placebo
T16 1412-1419 CI denotes placebo
T17 1628-1635 CI denotes placebo
T18 1763-1770 CI denotes placebo
T19 1978-1985 CI denotes placebo
T2 491-502 DP denotes prediabetes
T3 2403-2414 DP denotes prediabetes
T4 578-599 DP denotes 'controlled' diabetes
T5 507-526 DP denotes controlled diabetes
T6 2418-2437 DP denotes controlled diabetes
T7 107-115 DP denotes Diabetes
T8 641-658 CI denotes Jiangtang Xiaozhi
T9 396-413 CI denotes Jiangtang Xiaozhi

yangbin123xm_800_3

Id Subject Object Predicate Lexical cue
T1 107-115 DP denotes Diabetes
T5 641-658 CI denotes Jiangtang Xiaozhi
T6 396-413 CI denotes Jiangtang Xiaozhi
T7 1334-1351 CI denotes Jiangtang Xiaozhi
T8 1874-1891 CI denotes Jiangtang Xiaozhi
T9 2259-2276 CI denotes Jiangtang Xiaozhi
T10 1412-1419 CI denotes placebo
T13 671-678 CI denotes placebo
T14 1628-1635 CI denotes placebo
T15 1763-1770 CI denotes placebo
T16 1978-1985 CI denotes placebo
T17 491-502 DP denotes prediabetes
T18 563-574 DP denotes prediabetes
T19 2403-2414 DP denotes prediabetes
T20 507-526 DP denotes controlled diabetes
T21 2418-2437 DP denotes controlled diabetes
T22 578-599 DP denotes 'controlled' diabetes